Member Info for Seaking1

Try reading biospace, nature etc.

So, there are always other companies to invest in.

Radbury well said common sense really to some.

Well that’s good I will wait for news next week then. I have sold out for a nice profit . Next week I will buy back in on the news if it’s good. Are you certain there will be news next week as all directors say stuff like that a nd it doesn’t happen. Still your certain by the sounds of it.

If it’s good and the sp shoots up I will still be ok just buy straight away. :-)

May I remind you of your comments on the 3rd of this month, you said I quote, “Curevac will Fly on listing” well you were spot on well done. Could you send me one of your crystal balls please, they are very good :-)

Just had another read of the Washington post article on covid, very good info and much appreciated, thanks. I will make sure to have a look each month. I may have mentioned this before anyway biospace is worth a read.

And the good news is I only bought 40 @ 93 the rest were at 8681 and 8691. Therefore when I can take a profit on that I can then add to dabbling between Oxford biomedica, synairgen, and horizon discovery. So doing ok. Little chunks at a time. My great big chunk which my teeth are not letting go of! is in GSK. Very very undervalued.

Kernowlad,

I wouldn’t , they are on the cusp of making some serious money . I know the frustration you are feeling, but the business is solid and with all the contracts and new facilities now being used and more to open I think you will regret it. Your better off staying put and don’t sell as it’s a very good long term hold, with initial dividends not to far away.

They already have contracts for millions of vaccines from various companies covid and non covid,
I’m still waiting for my < 800 entry point.

There are some good chats on here now and again, but boy there are some morons . Don’t you guys get embarrassed writing drivel.

Definitely not. Unless it states SG001 it’s not Synairgen

My rns , to those who don’t know. Philips are making the nebulisers for synairgen .

I’m surprised that Abcam didn’t come back for another try. Having said that I think. dr Milner had a big influence,and he has now started investing on other startups in the Cambridge hub.

Definitely think the company is undervalued . As the prospects going forward have not come on the radar of the uk investors. When it’s stateside the sp will move up I expect. I feel it’s a good opportunity right now. Relatively speaking it’s new science don’t forget.

The one thing I would point out is not to just rely on this site to give you an up to date RNS in the past they have on many occasions been at least a day late.

Now that is good business and I hope GSK increase their holding. Very good company to be invested in, great science.

Try looking at the rns,s it gives you the dates.

Yes, I got sucked in at 93, silly me. So I will have to wait for an overpriced upturn. Luckily I don’t have a lot in AstraZeneca ,just 110 shares. Most of my cash is in GSK which I think is now quite undervalued.

Clarification.The next two quarters I mentioned didn’t include this one. I’m hoping for a drop to 90p for my next entry point.

I think it’s nearer to 10% stake. :-).

1st day of trading in the states and curevac goes from $16 to almost $56 250%. as I said good investment by GSK.